Endothelin(B) receptors in rabbit pulmonary resistance arteries: Effect of left ventricular dysfunction

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 3, 1998, Pages 895-903

  Docherty, Cheryl C ^a   Maclean, Margaret R ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; 3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR AGONIST; ENDOTHELIN RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SARAFOTOXIN; ENDOTHELIN RECEPTOR; POTASSIUM CHLORIDE; SEROTONIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; HEART LEFT VENTRICLE FAILURE; LUNG VASOCONSTRICTION; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RABBIT; ANIMAL; HEART LEFT VENTRICLE FUNCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY ARTERY; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

ANIMALS; ENDOTHELIUM, VASCULAR; NG-NITROARGININE METHYL ESTER; POTASSIUM CHLORIDE; PULMONARY ARTERY; RABBITS; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; SEROTONIN; VASOCONSTRICTION; VASODILATION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0031594130     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Arai H, Hori S, Arimori I, Ohkubo H and Nakanishi S (1990) Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348:730-732.
2. Arunlakshana O and Schild HO (1959) Some quantitative uses of antagonists. Br J Pharmacol Chemother 14:48-58.
3. Cody RJ, Haas GJ, Binkley PF, Capers Q and Kelley R (1992) Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 85:504-509.
4. Deuchar GA, Hicks MN, Cobbe SM, Docherty CC and MacLean MR (in press 1998) Pulmonary responses to 5-hydroxytryptamine and endothelin-1 in a rabbit model of left ventricular dysfunction. Cardiovasc Res.
5. Dochery CC and MacLean MR (1995) Effect of developmental age on noradrenaline-. and acetylcholine-evoked responses in rabbit isolated pulmonary resistance arteries. Br J Pharmacol 116:410P.
6. Douglas SA, Beck GR Jr, Elliott JD and Ohlstein EH (1995) Pharmacologic evidence for the presence of three functional endothelin receptor subtypes in the rabbit lateral saphenous vein. Br J Pharmacol 114:1529-1540.
7. Fukuroda T, Kobayayashi M, Ozaki S, Yano M, Miyauchi T, Onizuka M, Sugishita Y, Goto K and Nishikibe M (1994a) Endothelin receptor subtypes in human versus rabbit pulmonary arteries. J Appl Physiol 76(5):1976-1982.
8. Fukuroda T, Ozaki S, Ihara M, Ishikawa K, Yano M and Nishikibe M (1994b) Synergistic inhibition by BQ-123 and BQ-788 of endothelin-1-induced contractions of the rabbit pulmonary artery. Br J Pharmacol 113:336-338.
9. Habib F, Dutka D, Crossman D, Oakley CM and Cleland JGF (1994) Enhanced basal nitric oxide production in heart failure: Another failed counter-regulatory vasodilator mechanism? The Lancet 344:371-373.
10. B) receptors in rabbit isolated pulmonary artery and bronchus. Br J Pharmacol 118:1209-1217.
11. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K and Masaki T (1989) The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86:2863-2867.
12. Isaacson TC, Hampl V, Weir EK, Nelson DP and Archer SL (1994) Increased endothelium-derived NO in hypertensive pulmonary circulation of chronically hypoxic rats. J Appl Physiol 76:933-940.
13. Johns RA, Linden JM and Peach MJ (1989) Endothelium-dependent relaxation and cyclic GMP accumulation in rabbit pulmonary artery are selectively impaired by moderate hypoxia. Circ Res 65:1508-1515.
14. Karne S, Jayawirckreme CK and Lerner MR (1993) Cloning and characterisation of an endothelin-3 specific receptor (ETC receptor) from Xenopus laevis dermal melanophores. J Biochem Res 268:19126-19133.
15. Kemp BK, Smolich JJ and Cocks TM (1997) Evidence for specific regional patterns of responses to different vasoconstrictors and vasodilators in sheep isolated Pulmonary arteries and veins. Br J Pharmacol 121:441-450.
16. Kiowski W, Sütsch G, Hunziker P, Müller P, Kim J, Oechslin E, Schmitt R, Jones R and Bertel O (1995) Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet 346:732-736.
17. Kloog Y and Sokolovsky M (1989) Similarities in the mode and sites of action of sarafotoxin and endothelins. Trends Pharmacol Sci 10:212-214.
18. B receptors coexist on rabbit pulmonary artery vascular smooth muscle mediating contraction. Biochem Biophys Res Comm 196(1):209-215.
19. Leach RM, Twort CHM, Meron IRC, Cameron IR and Ward JPT (1992) A comparison of the pharmacological and mechanical properties in vitro of large and small pulmonary arteries of the rat. Clin Sci 82:55-62.
20. MacLean MR and Macmillan J (1993) Chronic inhibition of nitric oxide synthase: Effect on endothelium-dependent relaxation and sensitivity to sodium nitroprusside in rat pulmonary arteries. Br J Pharmacol 108:135P.
21. MacLean MR and McCulloch KM (in press 1998) Influence of applied tension and nitric oxide on responses to endothelins in rat pulmonary resistance arteries: Effect of chronically hypoxia. Br J Pharmacol.
22. B receptor-mediated vasoconstriction in rat pulmonary arteries and arterioles. J Cardiovasc Pharmacol 23:838-845.
23. MacLean MR, McCulloch KM and Baird M (1995) Effects of pulmonary hypertension on vasoconstrictor responses to endothelin-1 and sarafotoxin S6c and on inherent tone in rat pulmonary arteries. J Cardiovasc Pharmacol 26:822-830.
24. MacLean MR, Sweeney G, Baird M, McCulloch KM, Houslay M and Morecroft I (1996) 5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats. Br J Pharmacol 119:917-930.
25. Masaki T, Kimura S, Yanagisawa M and Goto K (1991) Molecular and cellular mechanisms of endothelin regulation, implications for vascular function. Circulation 84:1457-1468.
26. Masaki T, Yanagisawa M and Goto K (1992) Physiology and pharmacology of endothelins. Med Res Rev 12:391-421.
27. McCulloch KM, Docherty CC and MacLean MR (in press 1998) Endothelin receptors mediating contraction of rat and human pulmonary resistance arteries: Effect of chronic hypoxia in the rat. Br J Pharmacol.
28. McCulloch KM, Docherty CC, Morecroft I and MacLean MR (1996) EndothelinB receptors mediate contraction of human pulmonary resistance arteries. Br J Pharmacol 119:917-930.
29. B receptor-mediated contraction of human and rat pulmonary resistance arteries and the effect of pulmonary hypertension on endothelin responses in the rat. J Cardiovasc Pharmacol 26(3): S169-S176.
30. Mian KB and Martin W (1995) Differential sensitivity of basal and acetylcholine-stimulated activity of nitric oxide to destruction by Superoxide anion in rat aorta. Br J Pharmacol 115:993-1000.
31. Needleman P and Johnson EM (1973) Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther 184:709-715.
32. Ohlstein EH, Beck Jr GR, Douglas SA, Nambi P, Lago A, Gleason JG, Ruffolo Jr RR, Feuerstein G and Elliott JD (1994a) Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB209670. J Pharmacol Exper Ther 271: 762-768.
33. Ohlstein EH, Nambi P, Douglas SA, Edwards RM, Gellai M, Lago A, Leber JD, Cousins RD, Gao A, Frazee JS, Peishoff CE, Bean JW, Eggleston DS, Elshourbagy NA, Kumar C, Lee JA, Yue T, Louden C, Brooks DP, Weinstock J, Feuerstein G, Poste G, Ruffolo RR, Gleason JG and Elliott JD (1994b) SB209670, a rationally designed potent nonpeptide endothelin receptor antagonist Proc Natl Acad Sci USA 91:8052-8056.
34. Pye MP, Black M and Cobbe SM (1996) Comparison of in-vivo and in-vitro haemodynamic function in experimental heart failure - use of echocardiography. Cardiovasc Res 31(6):873-881.
35. Sakai S, Miyauchi T, Sakurai T, Yamaguchi I, Kobayashi G and Sugishita Y (1996) Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist. J Am Coll Cardiol 28:1580-1588.
36. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K and Masaki T (1990) Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348:732-735.
37. Sogabe K, Nirel H. Shouba M, Nomoto A, Ao S, Notsu Y and Ono T (1993) Pharmacological profile of FR 139317, a novel, potent, endothelin ETA receptor antagonist. J Pharmacol Exp Ther 264:1040-1046.
38. Sokolofsky M, Ambar I and Galron R (1992) A novel subtype of endothelin receptors. J Biol Chem 267:20551-20554.
39. Stewart DJ, Levy RD, Cernacek P and Langleben D (1991) Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease? Ann Intern Med 114:464-469.
40. Warner TD, Allcock GH, Corder R and Vane JR (1993) Use of endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and release of EDRF. Br J Pharmacol 110:777-782.
41. Xue C, Rengasamy A, Le Cras TD, Koberna PA, Dailey GC and Johns RA (1994) Distribution of NOS in normoxic vs. hypoxic rat lung: Up-regulation of NOS by chronic hypoxia. Am J Physiol 267:L667-L678.
42. Yoshibayashi M, Nishioka K, Nakao K, Saito Y, Matsumura M, Ueda T, Temma S, Shirakami G, Imura H and Mikawa H (1991) Plasma endothelin concentration in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in the pulmonary circulation. Circulation 84:2280-2285.